查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1434974

抗精神病藥物市場：按類別、適應症 - 2024-2030 年全球預測

Antipsychotic Drugs Market by Class (First Generation, Second Generation, Third Generation), Indication (Bipolar Disorders, Dementia, Schizophrenia) - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年抗精神病藥物市場規模為96.5億美元，預計2024年將達到104.2億美元，2030年將達到165.6億美元，複合年成長率為8.01%。

全球抗精神病藥物市場

主要市場統計
基準年[2023] 96.5億美元
預測年份 [2024] 104.2億美元
預測年份 [2030] 165.6億美元
複合年成長率（%） 8.01%
抗精神病藥物市場-IMG1

FPNV定位矩陣

FPNV定位矩陣對於評估抗精神病藥物市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對抗精神病藥物市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解：

1-市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2-市場開拓：我們深入研究利潤豐厚的新興市場，並分析它們在成熟細分市場中的滲透率。

3- 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1-抗精神病藥物市場的市場規模和預測是多少？

2-抗精神病藥物市場預測期內需要考慮投資的產品、細分市場、應用和領域有哪些？

3-抗精神病藥物市場的技術趨勢和法律規範是什麼？

4-抗精神病藥物市場主要供應商的市場佔有率是多少？

5-進入抗精神病藥物市場的適當型態或策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 精神疾病和相關疾病的盛行率增加
      • 政府核准的藥品增加
      • 人們對心理健康和保健的認知不斷增強
    • 抑制因素
      • 老牌品牌專利到期
    • 機會
      • 新型抗精神病藥物的研發及臨床試驗
      • 改良抗精神病藥物測試
    • 任務
      • 嚴格的法規結構和合規性
  • 市場區隔分析
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章抗精神病藥物市場：依類別

  • 第一代
    • 哈爾德
    • 納巴根
  • 第二代
    • 象齒象
    • 因維加
    • 拉圖達
    • 利培酮
    • Seroquel
    • Zyprexa
  • 第三代
    • Abilify

第7章依適應症分類的抗精神病藥物市場

  • 躁鬱症
  • 失智症
  • 思覺失調症
  • 單相憂鬱症

第8章美洲抗精神病藥物市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區抗精神病藥物市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲的抗精神病藥物市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：按主要企業分類
  • 主要企業競爭情境分析

第12章競爭產品組合

  • 主要公司簡介
    • AbbVie Inc.
    • Alkermes, Inc.
    • AMBOSS GmbH
    • Amgen Inc
    • Arlak Biotech
    • AstraZeneca PLC
    • Bristol-Myers Squibb Company
    • Daiichi Sankyo Company, Limited
    • Dr. Reddy's Laboratories, Ltd.
    • Eli Lilly and Company
    • Flagship Biotech International Pvt. Ltd.
    • GlaxoSmithKline PLC
    • H. Lundbeck A/S
    • Johnson & Johnson Services Inc.
    • Lifecare Neuro Products Ltd.
    • Luye Pharma Group
    • Merck & Co., Inc.
    • Novartis AG
    • Otsuka Pharmaceutical Co. Ltd.
    • Pfizer, Inc.
    • S. Karger AG
    • Seqirus Pty Ltd
    • Sumitomo Dainippon Pharma Co., Ltd.
    • Teva Pharmaceutical Industries, Ltd.
    • Vanda Pharmaceuticals Inc.
  • 主要產品系列

第13章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-AD36CD897CF3

[181 Pages Report] The Antipsychotic Drugs Market size was estimated at USD 9.65 billion in 2023 and expected to reach USD 10.42 billion in 2024, at a CAGR 8.01% to reach USD 16.56 billion by 2030.

Global Antipsychotic Drugs Market

KEY MARKET STATISTICS
Base Year [2023] USD 9.65 billion
Estimated Year [2024] USD 10.42 billion
Forecast Year [2030] USD 16.56 billion
CAGR (%) 8.01%
Antipsychotic Drugs Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Antipsychotic Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Antipsychotic Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Antipsychotic Drugs Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Alkermes, Inc., AMBOSS GmbH, Amgen Inc, Arlak Biotech, AstraZeneca PLC, Bristol-Myers Squibb Company, Daiichi Sankyo Company, Limited, Dr. Reddy's Laboratories, Ltd., Eli Lilly and Company, Flagship Biotech International Pvt. Ltd., GlaxoSmithKline PLC, H. Lundbeck A/S, Johnson & Johnson Services Inc., Lifecare Neuro Products Ltd., Luye Pharma Group, Merck & Co., Inc., Novartis AG, Otsuka Pharmaceutical Co. Ltd., Pfizer, Inc., S. Karger AG, Seqirus Pty Ltd, Sumitomo Dainippon Pharma Co., Ltd., Teva Pharmaceutical Industries, Ltd., and Vanda Pharmaceuticals Inc..

Market Segmentation & Coverage

This research report categorizes the Antipsychotic Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Class
    • First Generation
      • Haldo
      • Navane
    • Second Generation
      • Geodon
      • Invega
      • Latuda
      • Risperdal
      • Seroquel
      • Zyprexa
    • Third Generation
      • Abilify
  • Indication
    • Bipolar Disorders
    • Dementia
    • Schizophrenia
    • Unipolar Depression
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Antipsychotic Drugs Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Antipsychotic Drugs Market?

3. What are the technology trends and regulatory frameworks in the Antipsychotic Drugs Market?

4. What is the market share of the leading vendors in the Antipsychotic Drugs Market?

5. Which modes and strategic moves are suitable for entering the Antipsychotic Drugs Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Antipsychotic Drugs Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of psychosis and associated diseases
      • 5.1.1.2. Rising drug approval from governments
      • 5.1.1.3. Growing awareness regarding mental health and wellness
    • 5.1.2. Restraints
      • 5.1.2.1. Patent expiry of established brands
    • 5.1.3. Opportunities
      • 5.1.3.1. R&D and clinical trials for new antipsychotic drugs
      • 5.1.3.2. Improvements in antipsychotic drug testing
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory framework and compliance
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Antipsychotic Drugs Market, by Class

  • 6.1. Introduction
  • 6.2. First Generation
    • 6.3.1. Haldo
    • 6.3.2. Navane
  • 6.3. Second Generation
    • 6.4.1. Geodon
    • 6.4.2. Invega
    • 6.4.3. Latuda
    • 6.4.4. Risperdal
    • 6.4.5. Seroquel
    • 6.4.6. Zyprexa
  • 6.4. Third Generation
    • 6.5.1. Abilify

7. Antipsychotic Drugs Market, by Indication

  • 7.1. Introduction
  • 7.2. Bipolar Disorders
  • 7.3. Dementia
  • 7.4. Schizophrenia
  • 7.5. Unipolar Depression

8. Americas Antipsychotic Drugs Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Antipsychotic Drugs Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Antipsychotic Drugs Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

  • 12.1. Key Company Profiles
    • 12.1.1. AbbVie Inc.
    • 12.1.2. Alkermes, Inc.
    • 12.1.3. AMBOSS GmbH
    • 12.1.4. Amgen Inc
    • 12.1.5. Arlak Biotech
    • 12.1.6. AstraZeneca PLC
    • 12.1.7. Bristol-Myers Squibb Company
    • 12.1.8. Daiichi Sankyo Company, Limited
    • 12.1.9. Dr. Reddy's Laboratories, Ltd.
    • 12.1.10. Eli Lilly and Company
    • 12.1.11. Flagship Biotech International Pvt. Ltd.
    • 12.1.12. GlaxoSmithKline PLC
    • 12.1.13. H. Lundbeck A/S
    • 12.1.14. Johnson & Johnson Services Inc.
    • 12.1.15. Lifecare Neuro Products Ltd.
    • 12.1.16. Luye Pharma Group
    • 12.1.17. Merck & Co., Inc.
    • 12.1.18. Novartis AG
    • 12.1.19. Otsuka Pharmaceutical Co. Ltd.
    • 12.1.20. Pfizer, Inc.
    • 12.1.21. S. Karger AG
    • 12.1.22. Seqirus Pty Ltd
    • 12.1.23. Sumitomo Dainippon Pharma Co., Ltd.
    • 12.1.24. Teva Pharmaceutical Industries, Ltd.
    • 12.1.25. Vanda Pharmaceuticals Inc.
  • 12.2. Key Product Portfolio

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. ANTIPSYCHOTIC DRUGS MARKET RESEARCH PROCESS
  • FIGURE 2. ANTIPSYCHOTIC DRUGS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ANTIPSYCHOTIC DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ANTIPSYCHOTIC DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ANTIPSYCHOTIC DRUGS MARKET DYNAMICS
  • FIGURE 7. ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2023 VS 2030 (%)
  • FIGURE 8. ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 10. ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS ANTIPSYCHOTIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS ANTIPSYCHOTIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES ANTIPSYCHOTIC DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES ANTIPSYCHOTIC DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC ANTIPSYCHOTIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC ANTIPSYCHOTIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ANTIPSYCHOTIC DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 20. ANTIPSYCHOTIC DRUGS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ANTIPSYCHOTIC DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ANTIPSYCHOTIC DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
  • TABLE 6. ANTIPSYCHOTIC DRUGS MARKET SIZE, BY FIRST GENERATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ANTIPSYCHOTIC DRUGS MARKET SIZE, BY FIRST GENERATION, 2018-2030 (USD MILLION)
  • TABLE 8. ANTIPSYCHOTIC DRUGS MARKET SIZE, BY HALDO, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. ANTIPSYCHOTIC DRUGS MARKET SIZE, BY NAVANE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SECOND GENERATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SECOND GENERATION, 2018-2030 (USD MILLION)
  • TABLE 12. ANTIPSYCHOTIC DRUGS MARKET SIZE, BY GEODON, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INVEGA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. ANTIPSYCHOTIC DRUGS MARKET SIZE, BY LATUDA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. ANTIPSYCHOTIC DRUGS MARKET SIZE, BY RISPERDAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SEROQUEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. ANTIPSYCHOTIC DRUGS MARKET SIZE, BY ZYPREXA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. ANTIPSYCHOTIC DRUGS MARKET SIZE, BY THIRD GENERATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. ANTIPSYCHOTIC DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2030 (USD MILLION)
  • TABLE 20. ANTIPSYCHOTIC DRUGS MARKET SIZE, BY ABILIFY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 22. ANTIPSYCHOTIC DRUGS MARKET SIZE, BY BIPOLAR DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. ANTIPSYCHOTIC DRUGS MARKET SIZE, BY DEMENTIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SCHIZOPHRENIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. ANTIPSYCHOTIC DRUGS MARKET SIZE, BY UNIPOLAR DEPRESSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS ANTIPSYCHOTIC DRUGS MARKET SIZE, BY FIRST GENERATION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SECOND GENERATION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS ANTIPSYCHOTIC DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS ANTIPSYCHOTIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY FIRST GENERATION, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SECOND GENERATION, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY FIRST GENERATION, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SECOND GENERATION, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY FIRST GENERATION, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SECOND GENERATION, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO ANTIPSYCHOTIC DRUGS MARKET SIZE, BY FIRST GENERATION, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SECOND GENERATION, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO ANTIPSYCHOTIC DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES ANTIPSYCHOTIC DRUGS MARKET SIZE, BY FIRST GENERATION, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SECOND GENERATION, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES ANTIPSYCHOTIC DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES ANTIPSYCHOTIC DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC ANTIPSYCHOTIC DRUGS MARKET SIZE, BY FIRST GENERATION, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SECOND GENERATION, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC ANTIPSYCHOTIC DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC ANTIPSYCHOTIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY FIRST GENERATION, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SECOND GENERATION, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY FIRST GENERATION, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SECOND GENERATION, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY FIRST GENERATION, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SECOND GENERATION, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY FIRST GENERATION, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SECOND GENERATION, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN ANTIPSYCHOTIC DRUGS MARKET SIZE, BY FIRST GENERATION, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SECOND GENERATION, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN ANTIPSYCHOTIC DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY FIRST GENERATION, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SECOND GENERATION, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES ANTIPSYCHOTIC DRUGS MARKET SIZE, BY FIRST GENERATION, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SECOND GENERATION, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES ANTIPSYCHOTIC DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE ANTIPSYCHOTIC DRUGS MARKET SIZE, BY FIRST GENERATION, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SECOND GENERATION, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE ANTIPSYCHOTIC DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY FIRST GENERATION, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SECOND GENERATION, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN ANTIPSYCHOTIC DRUGS MARKET SIZE, BY FIRST GENERATION, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SECOND GENERATION, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN ANTIPSYCHOTIC DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND ANTIPSYCHOTIC DRUGS MARKET SIZE, BY FIRST GENERATION, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SECOND GENERATION, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND ANTIPSYCHOTIC DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM ANTIPSYCHOTIC DRUGS MARKET SIZE, BY FIRST GENERATION, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SECOND GENERATION, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM ANTIPSYCHOTIC DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY FIRST GENERATION, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SECOND GENERATION, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK ANTIPSYCHOTIC DRUGS MARKET SIZE, BY FIRST GENERATION, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SECOND GENERATION, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK ANTIPSYCHOTIC DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT ANTIPSYCHOTIC DRUGS MARKET SIZE, BY FIRST GENERATION, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SECOND GENERATION, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT ANTIPSYCHOTIC DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND ANTIPSYCHOTIC DRUGS MARKET SIZE, BY FIRST GENERATION, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SECOND GENERATION, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND ANTIPSYCHOTIC DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE ANTIPSYCHOTIC DRUGS MARKET SIZE, BY FIRST GENERATION, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SECOND GENERATION, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE ANTIPSYCHOTIC DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY ANTIPSYCHOTIC DRUGS MARKET SIZE, BY FIRST GENERATION, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SECOND GENERATION, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY ANTIPSYCHOTIC DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY FIRST GENERATION, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SECOND GENERATION, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY ANTIPSYCHOTIC DRUGS MARKET SIZE, BY FIRST GENERATION, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SECOND GENERATION, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY ANTIPSYCHOTIC DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS ANTIPSYCHOTIC DRUGS MARKET SIZE, BY FIRST GENERATION, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SECOND GENERATION, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS ANTIPSYCHOTIC DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY FIRST GENERATION, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SECOND GENERATION, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY ANTIPSYCHOTIC DRUGS MARKET SIZE, BY FIRST GENERATION, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SECOND GENERATION, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY ANTIPSYCHOTIC DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND ANTIPSYCHOTIC DRUGS MARKET SIZE, BY FIRST GENERATION, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SECOND GENERATION, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND ANTIPSYCHOTIC DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR ANTIPSYCHOTIC DRUGS MARKET SIZE, BY FIRST GENERATION, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SECOND GENERATION, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR ANTIPSYCHOTIC DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY FIRST GENERATION, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SECOND GENERATION, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY FIRST GENERATION, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SECOND GENERATION, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY FIRST GENERATION, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SECOND GENERATION, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN ANTIPSYCHOTIC DRUGS MARKET SIZE, BY FIRST GENERATION, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SECOND GENERATION, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN ANTIPSYCHOTIC DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN ANTIPSYCHOTIC DRUGS MARKET SIZE, BY FIRST GENERATION, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SECOND GENERATION, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN ANTIPSYCHOTIC DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND ANTIPSYCHOTIC DRUGS MARKET SIZE, BY FIRST GENERATION, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SECOND GENERATION, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND ANTIPSYCHOTIC DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY ANTIPSYCHOTIC DRUGS MARKET SIZE, BY FIRST GENERATION, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SECOND GENERATION, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY ANTIPSYCHOTIC DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES ANTIPSYCHOTIC DRUGS MARKET SIZE, BY FIRST GENERATION, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SECOND GENERATION, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES ANTIPSYCHOTIC DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM ANTIPSYCHOTIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM ANTIPSYCHOTIC DRUGS MARKET SIZE, BY FIRST GENERATION, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM ANTIPSYCHOTIC DRUGS MARKET SIZE, BY SECOND GENERATION, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM ANTIPSYCHOTIC DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM ANTIPSYCHOTIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 235. ANTIPSYCHOTIC DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 236. ANTIPSYCHOTIC DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 237. ANTIPSYCHOTIC DRUGS MARKET LICENSE & PRICING